Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in ratsPharmacology Biochemistry and Behavior · 2026-10-01A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01Subacute and long-term changes in cognitive functioning after administration of classic psychedelics, MDMA and ketamine: A systematic review of clinical and preclinical evidence.Neuroscience and biobehavioral reviews · 2026-08-14Real-world use, safety, and mental health efficacy of regulated psilocybin services in Oregon and ColoradomedRxiv · 2026-08-12A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10The Efficacy of Psilocybin Therapy for Depression in Parkinson's DiseaseClinicalTrials.gov · 2026-08-07Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs.ACS chemical neuroscience · 2026-08-05Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.Molecular psychiatry · 2026-07-28No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory studyJournal of Psychopharmacology · 2026-07-23Probing the Functional Magnetic Resonance Imaging Response to Psilocybin in Functional Neurological Disorder (PsiFUND)ClinicalTrials.gov · 2026-07-23Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the BrainClinicalTrials.gov · 2026-07-10Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health SymptomsJournal of Drug Issues · 2026-07-01Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic CircuitsHuman Brain Mapping · 2026-07-01Evidence that 5-HT receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.British journal of pharmacology · 2026-07-01Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?British journal of pharmacology · 2026-07-01Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment OutcomesResearch Square · 2026-06-19Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland.The international journal of neuropsychopharmacology · 2026-06-02Psychedelic Therapy and the Role of Music: A Scoping Review of Quantitative Evidence on Subjective and Objective Outcomes.Brain and behavior · 2026-06-01Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-07Human brain changes after first psilocybin useNature Communications · 2026-05-05356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s DiseaseBiological Psychiatry · 2026-05-01483. Acute Functional Brain Changes Associated With Psilocybin in Depression and Healthy Adults: A Systematic Review and Coordinate-Based Meta-AnalysisBiological Psychiatry · 2026-05-01The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.Journal of psychopharmacology (Oxford, England) · 2026-05-01Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsRepository for Publications and Research Data (ETH Zurich) · 2026-04-30A Double-blind, Randomized Trial Examining the Preliminary Efficacy of Psilocybin Therapy for People With Chronic Low Back PainClinicalTrials.gov · 2026-04-29Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twinsFrontiers in Psychiatry · 2026-04-21Effects of a single dose of psilocybin on diet-induced weight loss in obese miceTranslational Psychiatry · 2026-04-14Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-10Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studiesReligion Brain & Behavior · 2026-03-31Psychedelic-Induced Constraint Destabilization and Reconstruction as a Mechanism for Cognitive ResetZenodo (CERN European Organization for Nuclear Research) · 2026-03-25Psychedelic-Assisted Psychotherapy: Attitudes of Law Enforcement and Military PersonnelJournal of Police and Criminal Psychology · 2026-03-22Synthesis and Characterization of Psilocybin Metabolites and Deuterated AnalogsACS Chemical Neuroscience · 2026-03-18Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials.ACS pharmacology & translational science · 2026-03-13Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping reviewJournal of Psychedelic Studies · 2026-03-09Nicotinoyl-Tryptamine Derivatives as Potential Dual-Action Prodrugs for NAD⁺ Enhancement and NeuroprotectionZenodo (CERN European Organization for Nuclear Research) · 2026-03-01Low-income group psilocybin assisted therapy for depression: An Oregon feasibility studyJournal of Psychedelic Studies · 2026-02-12Approved and Pipeline Pharmacological Interventions for Eating Disorders (2010-2025): 15 Years of Progress (or Lack Thereof).CNS drugs · 2026-02-01Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape.The Australian and New Zealand journal of psychiatry · 2026-02-01Presence of 4-Hydroxy--methyl--ethyltryptamine in Commercially Available Products.ACS omega · 2026-01-20Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 StudyPsychedelic Medicine · 2026-01-18Psychedelics distinctly alter brain entropy and complexity compared to psychostimulantsmedRxiv · 2026-01-16Intentions, Spirituality, Set, and Setting Are Associated with Mystical Experiences in Psilocybin-Assisted TherapyPsychedelic Medicine · 2026-01-12Psilocybin Treatment for Refractory Depression: A Clinical ReviewDigital Commons - Gardner-Webb University (Gardner-Webb University) · 2026-01-01Healthcare Providers' Perspectives on Psychedelic-Assisted Therapies Across Clinical Contexts: "I Can Offer Medical Assistance in Dying, but I Can't Prescribe Psychedelics".Global advances in integrative medicine and health · 2026-01-01Toward Standardized Products Containing Biomass of Psilocybe Cubensis Fungi.Journal of AOAC International · 2026-01-01Perceptions of Psilocybin-Assisted Psychotherapy and Standard Interventions for Nicotine Cessation.Journal of psychoactive drugs · 2026-01-01An exploration of the relationships between the effects of psilocybin on behavior, 5-HT receptor occupancy, and neuroplastic effects in mice.Journal of psychopharmacology (Oxford, England) · 2026-01-01Rural-Urban Disparities in Access to Interventional Psychiatry Treatments among VA Patients.Rural mental health · 2026-01-01Wherefore the magic? The evolutionary role of psilocybin in naturebioRxiv · 2025-12-19Sudden Loss of Consciousness Following Psilocybin Ingestion.The American journal of psychiatry · 2025-12-01Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community.Harm reduction journal · 2025-11-25Sex-specific role of the 5-HT receptor in psilocybin-induced extinction of opioid reward.Nature communications · 2025-11-20Comparative Efficacy of Psilocybin and MDMA in PTSD Treatment: A Systematic Review of Long-Term OutcomesBerkeley Scientific Journal · 2025-11-12The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives.Pharmacology, biochemistry, and behavior · 2025-11-01A Systematic Review and Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Use Disorder.Healthcare (Basel, Switzerland) · 2025-10-23Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older AdultsClinicalTrials.gov · 2025-10-21Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with Obsessive-Compulsive Disorder: International findings from the LATINO Study.UNC Libraries · 2025-10-09Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior.Progress in neuro-psychopharmacology & biological psychiatry · 2025-10-02Understanding psilocybin mushrooms and aiding in setting standards for a burgeoning industry in JamaicaPhytochemistry Letters · 2025-10-01Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathwayNaunyn-Schmiedeberg's Archives of Pharmacology · 2025-10-01363. DIFFERENTIAL EFFECTS OF PSILOCYBIN AND LISURIDE ON SEROTONIN AND DOPAMINE NEURONAL ACTIVITY AND BEHAVIORThe international journal of neuropsychopharmacology · 2025-08-01Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.Psychopharmacology · 2025-08-01Females in Psychedelic Research: A Perspective for Advancing Research and Practice.ACS pharmacology & translational science · 2025-07-11Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-07-01Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.Brain and behavior · 2025-07-01Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-PositionJournal of Labelled Compounds and Radiopharmaceuticals · 2025-07-01Psilocybin With Intracranial Neural SensingClinicalTrials.gov · 2025-06-06Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice.The international journal of neuropsychopharmacology · 2025-06-06Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical PopulationmedRxiv · 2025-05-29Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new: A narrative review on psychedelics and anaesthesia.European journal of anaesthesiology · 2025-05-01Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement.BMJ open · 2025-04-15Effects of a single dose of psilocybin on diet-induced weight loss in obese miceResearch Square · 2025-03-31Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015-2020.Journal of psychoactive drugs · 2025-03-03A systematic review of participant diversity in psychedelic-assisted psychotherapy trials.Psychiatry research · 2025-03-01The safety of psilocybin-assisted psychotherapy: A systematic review.The Australian and New Zealand journal of psychiatry · 2025-02-01The Acceptability of Psychedelic-Assisted Therapy Amongst Mental Health Consumers: Utilising the Theory of Planned Behaviour.International journal of mental health nursing · 2025-02-01Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot StudyClinicalTrials.gov · 2025-01-01Association of Hallucinogen Persisting Perception Disorder with Trait Neuroticism and Mental Health Symptoms.Journal of psychoactive drugs · 2025-01-01Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration.The American journal of psychiatry · 2025-01-01Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial.The American journal of psychiatry · 2025-01-01Geographical Differences in Self-Reported Past 12-Month Drug Use: Results from the NDEWS Rapid Street Reporting, 2021-2023.Substance use & misuse · 2025-01-01Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.Therapeutic advances in psychopharmacology · 2025-01-01Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models.Frontiers in systems neuroscience · 2025-01-01Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat.Frontiers in psychiatry · 2025-01-01The many faces of psilocybin-related psychosis: A case seriesPsychiatry Research Case Reports · 2024-12-07Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.JAMA network open · 2024-12-02Impact of psilocybin on cognitive function: A systematic review.Psychiatry and clinical neurosciences · 2024-12-01Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuitsbioRxiv · 2024-11-07Psilocybin-assisted psychotherapy for existential distress: practical considerations for therapeutic application-a review.Annals of palliative medicine · 2024-11-01Human brain changes after first psilocybin usebioRxiv · 2024-10-14Resurrecting Ancestral Familial Health: A Role for Psilocybin?The Family Journal · 2024-08-09Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.Psychopharmacology · 2024-08-01Psychedelic-assisted psychotherapy: where is the psychotherapy research?Psychopharmacology · 2024-08-01The cyclical revival of psychedelics in psychiatric treatment.Current medical research and opinion · 2024-08-01Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness.Current neurology and neuroscience reports · 2024-08-01Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression.Trials · 2024-07-03Regional Differences of Self-Reported Past-12-month Marijuana, Psilocybin, and Cocaine Use: Results From NDEWS Rapid Street Reporting 2021-2022Drug and Alcohol Dependence · 2024-07-01Increased 5-HT2A receptor signalling efficacy differentiates serotonergic psychedelics from non-psychedelicsbioRxiv · 2024-06-16The Intersection of Mental Health and Sexual and Gender Minority Identities for Older Adults Living with Human Immunodeficiency Virus: A Narrative Review.The Nursing clinics of North America · 2024-06-01In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials.Psychopharmacology · 2024-06-01A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?Psychedelic medicine (New Rochelle, N.Y.) · 2024-06-01Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians.Journal of eating disorders · 2024-04-24Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometryAnalytica Chimica Acta · 2024-02-01Rapid-acting antidepressant drugs modulate affective bias in rats.Science translational medicine · 2024-01-10Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority TrialResearch Square · 2024-01-04Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and NecessaryAmerican Journal of Psychiatry · 2024-01-01Educational Materials and Image Induction Increase Treatment Credibility.Journal of psychoactive drugs · 2024-01-01The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies.Journal of psychopharmacology (Oxford, England) · 2024-01-01Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.The American journal of psychiatry · 2024-01-01Psilocybin Without Psychotherapy: A Cart Without a Horse?The American journal of psychiatry · 2024-01-01Safety pharmacology of acute psilocybin administration in healthy participants.Neuroscience applied · 2024-01-01Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.Journal of psychoactive drugs · 2024-01-01Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations.Current biology: CB · 2023-12-04Wood-loving magic mushrooms from Australia are saprotrophic invaders in the northern hemisphereAuthorea Preprints · 2023-11-17The entropic heart: Tracking the psychedelic state via heart rate dynamicsbioRxiv · 2023-11-09"But the reality is it's happening": A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy.The International journal of eating disorders · 2023-11-01Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2023-10-01Expectancies for Subjective and Antidepressant Effects in Psilocybin UsersJournal of Humanistic Psychology · 2023-09-22Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.JAMA · 2023-09-05Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.Journal of affective disorders · 2023-04-14Canalization and plasticity in psychopathology.Neuropharmacology · 2023-03-15Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice.Psychedelic medicine (New Rochelle, N.Y.) · 2023-03-01How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?Journal of psychoactive drugs · 2023-01-01Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption.Journal of psychopharmacology (Oxford, England) · 2023-01-01Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders.Frontiers in psychiatry · 2023-01-01Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials.Journal of psychoactive drugs · 2023-01-01Manic episode following psilocybin use in a man with bipolar II disorder: a case report.Frontiers in psychiatry · 2023-01-01From prohibited to prescribed: The rescheduling of MDMA and psilocybin in AustraliaDrug Science Policy and Law · 2022-12-31Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.Contemporary clinical trials · 2022-12-01Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.ACS pharmacology & translational science · 2022-11-11Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.Headache · 2022-11-01An Exploratory Open-Label, Phase 1b, Ascending Dose Study to Evaluate the Effects of Oral 3-[2-(Dimethylamino)Ethyl]-1h-indol-4-yl Dihydrogen Phosphate (Psilocybin, BPL-PSILO) on Cognition in Patients With Chronic Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)ClinicalTrials.gov · 2022-10-12Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.JAMA psychiatry · 2022-10-01Psychedelics for Psychiatric Disorders: Promise, Not PanaceaPsychiatric Annals · 2022-09-01Association of Psilocybin Use in Adolescents with Major Depressive EpisodeEuropean psychiatry: the journal of the Association of European Psychiatrists · 2022-09-01Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations.Neuropharmacology · 2022-08-15A Single Method for 127 Recommended and Additional DUID Drugs in Blood and Urine by LC-MS-MS.Journal of analytical toxicology · 2022-07-14Association of Psilocybin Use in Adolescents with Major Depressive EpisodeEuropean Psychiatry · 2022-06-01Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice.Psychopharmacology · 2022-06-01Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.Psychopharmacology · 2022-06-01The promises and perils of psychedelic pharmacology for psychiatry.Nature reviews. Drug discovery · 2022-06-01Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2022-05-01Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon.Cureus · 2022-05-01184. Hallucinogens on TikTokJournal of Adolescent Health · 2022-03-10Psychedelics hold promise for primary care researchFamily Practice · 2022-01-24Comparison of subjective, autonomic, and endocrine effects of LSD and psilocybin in healthy subjectsNeuroscience Applied · 2022-01-01Standards Without Labs: Drug Development in the Psychedelic UndergroundCitizen Science Theory and Practice · 2022-01-01Psychedelic medicines for mood disorders: current evidence and clinical considerations.Current opinion in psychiatry · 2022-01-01Psilocybin for Trauma-Related Disorders.Current topics in behavioral neurosciences · 2022-01-01Self-administration of Psilocybin in the Setting of Treatment-resistant Depression.Innovations in clinical neuroscience · 2022-01-01Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression.Journal of psychoactive drugs · 2022-01-01"A sense of the bigger picture:" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use.PloS one · 2022-01-01Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence.Spirituality in Clinical Practice · 2021-09-01Blinding and expectancy confounds in psychedelic randomized controlled trials.Expert review of clinical pharmacology · 2021-09-01Psilocybin for Depression.The New England journal of medicine · 2021-08-26Cannabis-induced oceanic boundlessness.Journal of psychopharmacology (Oxford, England) · 2021-07-01Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological AnalysisJournal of Humanistic Psychology · 2021-06-12Future Directions for Clinical Psilocybin Research: The Relaxed Symptom NetworkPsyArXiv · 2021-05-19Future Directions for Clinical Psilocybin Research: The Relaxed Symptom NetworkPsyArXiv · 2021-05-19Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience.ACS pharmacology & translational science · 2021-04-09Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case StudiesmedRxiv · 2021-04-07The Return of Psychedelics: Still Time to Prevent TragedyPsychiatric News · 2021-03-31Blinding and Expectancy Confounds in Psychedelic Randomised Controlled TrialsPsyArXiv · 2021-03-08Blinding and Expectancy Confounds in Psychedelic Randomised Controlled TrialsPsyArXiv · 2021-03-08How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and TranscendenceAnesthesia & Analgesia · 2021-02-17Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS SurvivorsClinicalTrials.gov · 2021-01-07Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics · 2021-01-01MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogensNeuropsychopharmacology · 2020-11-19Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials.Drug testing and analysis · 2020-10-01Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.EClinicalMedicine · 2020-10-01Psilocybin rescues sociability deficits in an animal model of autismbioRxiv · 2020-09-10Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of PsilocybinACS Omega · 2020-07-14An Improved, Practical, and Scalable Five-Step Synthesis of PsilocybinSynthesis · 2020-01-08Psilocybin for depression: Considerations for clinical trial designJournal of Psychedelic Studies · 2019-09-01T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS SurvivorsBiological Psychiatry · 2019-04-30Psychedelic-assisted therapy for anxiety and depression in the face of death: A critical review with an anthropological lensJournal of Psychedelic Studies · 2019-02-25Serotonergic Psychedelics LSD & Psilocybin Increase the Fractal Dimension of Cortical Brain Activity in Spatial and Temporal DomainsbioRxiv · 2019-01-11Psychedelic-Assisted Group Therapy: A Systematic Review.Journal of psychoactive drugs · 2019-01-01Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar ratsBehavioural Pharmacology · 2018-09-01Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogensbioRxiv · 2018-07-24Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.Frontiers in psychology · 2018-01-01The Effects of LSD and Psilocin on Anxiety-Related Behaviours in ZebrafishStudent Research Proceedings · 2017-05-15Spirituality and Hallucinogen Use: Results from a Pilot Study among College StudentsInternational Journal of Transpersonal Studies · 2012-06-30Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds.The International journal on drug policy · 2010-11-01Between prohibitions: patterns and meanings of magic mushroom use in the UK.Substance use & misuse · 2008-01-01Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.Neuron · 2007-02-01Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.Addictive behaviors · 2004-06-01Patterns of recreational drug use at dance events in Edinburgh, Scotland.Addiction (Abingdon, England) · 2001-07-01Serotonin-like and antiserotonin properties of psilocybin and psilocin.Science (New York, N.Y.) · 1962-06-01